Synthesis and antitumor activity evaluation of quinazoline derivatives bearing piperazine-1-carbodithioate moiety at C4-position.

[1]  M. Akhter,et al.  Piperazine scaffold: A remarkable tool in generation of diverse pharmacological agents. , 2015, European journal of medicinal chemistry.

[2]  N. Shankaraiah,et al.  Dithiocarbamate/piperazine bridged pyrrolobenzodiazepines as DNA-minor groove binders: synthesis, DNA-binding affinity and cytotoxic activity. , 2015, Bioorganic chemistry.

[3]  R. Konwar,et al.  Novel alkylphospholipid-DTC hybrids as promising agents against endocrine related cancers acting via modulation of Akt-pathway. , 2014, European journal of medicinal chemistry.

[4]  P. Depreux,et al.  Inhibition of tumor cell growth and angiogenesis by 7-aminoalkoxy-4-aryloxy-quinazoline ureas, a novel series of multi-tyrosine kinase inhibitors. , 2014, European journal of medicinal chemistry.

[5]  D. Mobley,et al.  Triazole-dithiocarbamate based selective lysine specific demethylase 1 (LSD1) inactivators inhibit gastric cancer cell growth, invasion, and migration. , 2013, Journal of medicinal chemistry.

[6]  S. W. Park,et al.  An evolving role of piperazine moieties in drug design and discovery. , 2013, Mini reviews in medicinal chemistry.

[7]  Xingzhi Xu,et al.  Synthesis and antiproliferative evaluation of piperazine-1-carbothiohydrazide derivatives of indolin-2-one. , 2013, Bioorganic & medicinal chemistry letters.

[8]  Xingzhi Xu,et al.  Synthesis and antiproliferative activity of 4-substituted-piperazine-1-carbodithioate derivatives of 2,4-diaminoquinazoline. , 2013, European journal of medicinal chemistry.

[9]  T. Szekeres,et al.  Synthesis antimicrobial and anticancer activity of N′-arylmethylidene-piperazine-1-carbothiohydrazide , 2013, Medicinal Chemistry Research.

[10]  Xiao-Jing Shi,et al.  Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents. , 2013, European journal of medicinal chemistry.

[11]  C. Teng,et al.  Effector mechanisms of sunitinib-induced G1 cell cycle arrest, differentiation, and apoptosis in human acute myeloid leukaemia HL60 and KG-1 cells , 2013, Annals of Hematology.

[12]  S. Belinsky,et al.  A phase I study of 5-azacytidine and erlotinib in advanced solid tumor malignancies , 2012, Cancer Chemotherapy and Pharmacology.

[13]  D. Gandara,et al.  A phase II trial of gefitinib and pegylated IFNα in previously treated renal cell carcinoma , 2011, International Journal of Clinical Oncology.

[14]  Wei Huang,et al.  Synthesis and antitumor activity of novel dithiocarbamate substituted chromones. , 2009, European journal of medicinal chemistry.

[15]  K. Rangappa,et al.  Synthesis and in vitro antiproliferative activity of novel 1-benzhydrylpiperazine derivatives against human cancer cell lines. , 2009, European journal of medicinal chemistry.

[16]  W. Guo,et al.  Effect of TM208 on QGY-7703 xenograft tumor growth , 2008, Anti-cancer drugs.

[17]  U. Jordis,et al.  Improved synthesis of substituted 6,7-dihydroxy-4-quinazolineamines: tandutinib, erlotinib and gefitinib. , 2006, Molecules.

[18]  Yuyang Jiang,et al.  Synthesis and in vitro antitumor activity of 4(3H)-quinazolinone derivatives with dithiocarbamate side chains. , 2005, Bioorganic & medicinal chemistry letters.

[19]  Donna Neuberg,et al.  CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML). , 2002, Cancer cell.